Canada markets close in 6 hours 8 minutes

Item 9 Labs Corp. (INLB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9700-0.0300 (-3.00%)
As of 09:30AM EST. Market open.

Item 9 Labs Corp.

2727 North 3rd Street
Suite 201
Phoenix, AZ 85004
United States
833 867 6337

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees72

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew Douglas BowdenCEO & Director169.23kN/A1988
Mr. Robert E. MikkelsenSec., Treasurer & CFO134.62kN/A1982
Mr. Christopher Leland WolvenChief Operating Officer155.77kN/A1983
Mr. Jeffrey I. RassasChief Strategy Officer & Director196.7kN/A1963
Mr. Mike Keskey IIGen. CounselN/AN/AN/A
Jayne LevyDirector of CommunicationsN/AN/AN/A
Kyle JenningsVP of MarketingN/AN/AN/A
Mr. Michael WeinbergerChief Franchise Officer & DirectorN/AN/A1978
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers products through licensed dispensaries to consumers in Arizona. As of July 7, 2021, the company had one dispensary. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Corporate Governance

Item 9 Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.